Kenichi Utano

Kenichi Utano

Auto-generated profile, based on publicly available information

Kenichi Utano

Department of Coloproctology, Aizu Medical Center, Fukushima Medical University, Aizuwakamatsu-city, Japan

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in World Journal of Gastroenterology
Verified
Journal Article
Open access
SKShigeyoshi Kijima
Shigeyoshi Kijima
TSTakahiro Sasaki
Takahiro Sasaki
KNKoichi Nagata
Koichi Nagata
KUKenichi Utano
Kenichi Utano
Alan LeforAlan Lefor
Alan Lefor
HSHideharu Sugimoto
Hideharu Sugimoto
Imaging studies are a major component in the evaluation of patients for the screening, staging and surveillance of colorectal cancer. This review presents commonly encountered findings in the diagnosis and staging of patients with colorectal cancer using computed tomography (CT) colonography, magnetic resonance imaging (MRI), and positron emission tomography (PET)/CT colonography. CT colonography provides important information for the preoperative assessment of T staging. Wall deformities are associated with muscular or subserosal invasion. Lymph node metastases from colorectal cancer often present with calcifications. CT is superior to detect calcified metastases. Three-dimensional CT to image the vascular anatomy facilitates laparoscopic surgery. T staging of rectal cancer by MRI is an established modality because MRI can diagnose rectal wall laminar structure. N staging in patients with colorectal cancer is still challenging using any imaging modality. MRI is more accurate than CT for the evaluation of liver metastases. PET/CT colonography is valuable in the evaluation of extra-colonic and hepatic disease. PET/CT colonography is useful for obstructing colorectal cancers that cannot be traversed colonoscopically. PET/CT colonography is able to localize synchronous colon cancers proximal to the obstruction precisely. However, there is no definite evidence to support the routine clinical use of PET/CT colonography.

1 August 2017 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
HIHiroaki Ikematsu
Hiroaki Ikematsu
TSTaku Sakamoto
Taku Sakamoto
KTKazutomo Togashi
Kazutomo Togashi
NYNaohisa Yoshida
Naohisa Yoshida
THTakashi Hisabe
Takashi Hisabe
YSYutaka Saito
Yutaka Saito

1 June 2008 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
KUKenichi Utano
Kenichi Utano
KEKazuhiro Endo
Kazuhiro Endo
KTKazutomo Togashi
Kazutomo Togashi
JSJunichi Sasaki
Junichi Sasaki
HKHiroshi J. Kawamura
Hiroshi J. Kawamura
HSHideharu Sugimoto
Hideharu Sugimoto
Und the intestine were studied to assess their relations to T stage. Intestinal wall deformity was classified into arc type, trapezoid type, and apple-core type, defined as a trapezoidal wall deformity involving ≥50 percent of the circumference of the lumen. Results: As for intestinal wall deformity, the rate of arc type was higher in Tis/T1 than in T2 (74 percent: 17/23vs. 24 percent: 8/34,P< 0.0001); the rate of trapezoid type was 17 percent (4/23) in Tis/T1, 59 percent (20/34) in T2, and 15 percent (28/189) in T3/T4 (Tis/T1vs.T2,P< 0.0001; T2vs. T3/T4,P< 0.0001); and the rate of apple-core type was lower in T2 than in T3/T4 (18 percent: 6/34vs. 81 percent: 154/189,P< 0.0001). Arc type, trapezoid type, and apple-core type were primarily associated with T1, T2, and T3/T4, respectively. When these criteria were used, the overall accuracy for T stage was 79 percent. Rough appearance was specific for T3/T4, but insensitive. Conclusions: CT colonography can provide important information for the preoperative assessment of T stage in colorectal cancer. Presented at the meeting of United European Gastroenterology, Berlin, Germany, October 21 to 25, 2006. e-mail: ktogashi@jichi.ac.jp © The ASCRS 2008...

31 August 2015 in Therapeutic Advances in Gastroenterology
Verified
Journal Article
Open access
KTKazutomo Togashi
Kazutomo Togashi
DNDaiki Nemoto
Daiki Nemoto
KUKenichi Utano
Kenichi Utano
NINoriyuki Isohata
Noriyuki Isohata
KKKensuke Kumamoto
Kensuke Kumamoto
Alan LeforAlan Lefor
Alan Lefor
Blue laser imaging is a new system for image-enhanced endoscopy using laser light. Blue laser imaging utilizes two monochromatic lasers (410 and 450 nm) instead of xenon light. A 410 nm laser visualizes vascular microarchitecture, similar to narrow band imaging, and a 450 nm laser provides white light by excitation. According to three recently published reports, the diagnostic ability of polyp characterization using blue laser imaging compares favorably with narrow band imaging. No published data are available to date regarding polyp detection with blue laser imaging. However, blue laser imaging has the possibility to increase the detection of colorectal polyps by depicting brighter and clearer endoscopic images, even at a distant view, compared with first-generation image-enhanced endoscopy. A clinical trial to compare the detection between blue laser imaging and xenon light is warranted.

1 January 2017 in American Journal of Gastroenterology
Verified
Journal Article
Open access
PDF file
KNKoichi Nagata
Koichi Nagata
SEShungo Endo
Shungo Endo
THTetsuro Honda
Tetsuro Honda
TYTakaaki Yasuda
Takaaki Yasuda
MHMichiaki Hirayama
Michiaki Hirayama
Hiroyuki YoshidaHiroyuki Yoshida
Hiroyuki Yoshida
The objective of this study was to assess prospectively the diagnostic accuracy of computer-assisted computed tomographic colonography (CTC) in the detection of polypoid (pedunculated or sessile) and nonpolypoid neoplasms and compare the accuracy between gastroenterologists and radiologists. This nationwide multicenter prospective controlled trial recruited 1,257 participants with average or high risk of colorectal cancer at 14 Japanese institutions. Participants had CTC and colonoscopy on the same day. CTC images were interpreted independently by trained gastroenterologists and radiologists. The main outcome was the accuracy of CTC in the detection of neoplasms ≥6 mm in diameter, with colonoscopy results as the reference standard. Detection sensitivities of polypoid vs. nonpolypoid lesions were also evaluated. Of the 1,257 participants, 1,177 were included in the final analysis: 42 (3.6%) were at average risk of colorectal cancer, 456 (38.7%) were at elevated risk, and 679 (57.7%) had recent positive immunochemical fecal occult blood tests. The overall per-participant sensitivity, specificity, and positive and negative predictive values for neoplasms ≥6 mm in diameter were 0.90, 0.93, 0.83, and 0.96, respectively, among gastroenterologists and 0.86, 0.90, 0.76, and 0.95 among radiologists (P<0.05 for gastroenterologists vs. radiologists). The sensitivity and specificity for neoplasms ≥10 mm in diameter were 0.93 and 0.99 among gastroenterologists and 0.91 and 0.98 among radiologists (not significant for gastroenterologists vs. radiologists). The CTC interpretation time by radiologists was shorter than that by gastroenterologists (9.97 vs. 15.8 min, P<0.05). Sensitivities for pedunculated and sessile lesions exceeded those for flat elevated lesions ≥10 mm in diameter in both groups (gastroenterologists 0.95, 0.92, and 0.68; radiologists: 0.94, 0.87, and 0.61; P0.05) for gastroenterologists vs. radiologists. CTC interpretation by gastroenterologists and radiologists was accurate for detection of polypoid neoplasms, but less so for nonpolypoid neoplasms. Gastroenterologists had a higher accuracy in the detection of neoplasms ≥6 mm than did radiologists, although their interpretation time was longer than that of radiologists.

20 March 2021 in Molecular and Clinical Oncology
Verified
Journal Article
Open access
PDF file
TNTetsutaro Nemoto
Tetsutaro Nemoto
SEShungo Endo
Shungo Endo
NINoriyuki Isohata
Noriyuki Isohata
DTDaisuke Takayanagi
Daisuke Takayanagi
DNDaiki Nemoto
Daiki Nemoto
KTKazutomo Togashi
Kazutomo Togashi
The neutrophil‑to‑lymphocyte ratio (NLR) has been reported to be an independent prognostic factor of unresectable advanced or metastatic colorectal cancer (uCRC). However, few studies have documented changes in NLR during chemotherapy. The current study analyzed whether a change in NLR during chemotherapy in patients with uCRC could be used as a prognostic biomarker. The present retrospective study enrolled 71 patients who received first‑line chemotherapy for uCRC between April 2012 and April 2019. The exclusion criteria were as follows: Acute infection or systemic inflammatory disease, duration of first‑line chemotherapy <3 months, curative resection after chemotherapy and treatment with granulocyte‑colony stimulating factor within 1 month. NLR, Lymphocyte‑to‑monocyte ratio (LMR), platelet‑to‑­lymphocyte ratio (PLR), lactate dehydrogenase, alkaline phosphatase (ALP), albumin, carcinoembryonic antigen (CEA) and carbohydrate antigen 19‑9 (CA19‑9) levels were calculated before chemotherapy and at 3 months after chemotherapy. Among these laboratory data, NLR, PLR, ALP, CEA and CA19‑9 levels were significantly decreased during chemotherapy. For Cox univariate analyses, these five data makers were divided into two groups: Decreased and increased (comparing before and at 3 months after chemotherapy). Only the change in NLR was significantly associated with overall survival (P=0.0002). Furthermore, the overall survival (P<0.0001) and progression‑free survival (P=0.0041) of patients with decreased NLR was increased compared with patients with increased NLR. The change in NLR from pre‑chemotherapy to 3 months following chemotherapy was determined to be a predictor of prognosis in patients with uCRC. The ability to predict prognosis at an early phase of chemotherapy may provide useful information for the selection of subsequent treatment and may improve the quality of patient life.